Site Editor

Thomas Flaig, MD


Terence Friedlander, MD, on Sequencing of Chemotherapy and Immunotherapy for Bladder Cancer: Present and Future

Posted: Friday, November 17, 2023

Terence Friedlander, MD, of the UCSF Helen Diller Family Comprehensive Cancer Center, gives an overview of the landscape of bladder cancer treatment and what the future may look like for using chemotherapy and immunotherapy in this patient population.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.